CN107290444A - The method for detecting neopterin and biopterin in human urine - Google Patents

The method for detecting neopterin and biopterin in human urine Download PDF

Info

Publication number
CN107290444A
CN107290444A CN201710373546.5A CN201710373546A CN107290444A CN 107290444 A CN107290444 A CN 107290444A CN 201710373546 A CN201710373546 A CN 201710373546A CN 107290444 A CN107290444 A CN 107290444A
Authority
CN
China
Prior art keywords
sample
treatment
urine
liquid phase
chromatographic column
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710373546.5A
Other languages
Chinese (zh)
Other versions
CN107290444B (en
Inventor
陈静宜
程雅婷
陈智
刘伟霞
赵蓓蓓
李维
佘旭辉
禤学怡
李卓阳
董衡
沙小花
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Kingmed Diagnostics Central Co Ltd
Original Assignee
Guangzhou Kingmed Diagnostics Central Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Kingmed Diagnostics Central Co Ltd filed Critical Guangzhou Kingmed Diagnostics Central Co Ltd
Priority to CN201710373546.5A priority Critical patent/CN107290444B/en
Publication of CN107290444A publication Critical patent/CN107290444A/en
Application granted granted Critical
Publication of CN107290444B publication Critical patent/CN107290444B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Analyzed the invention discloses a kind of method of neopterin and biopterin in accurate, quick, high flux detection human urine, including by the urine sample after pre-treatment with liquid chromatogram, chromatographic column is reverse bonding silicagel column;Mobile phase is methanol and ammonium acetate buffer, gradient elution;Detected afterwards with fluorescence detector.The inventive method cost is low, and pre-treatment is simple, and batch processing detection can be achieved, and optimization chromatographic process shortens analysis time, greatly improves sample flux, is particularly suitable for use in demand of the clinical and routine testing to chromatographic process.

Description

The method for detecting neopterin and biopterin in human urine
Technical field
The present invention relates to a kind of detection method, more particularly to a kind of side for detecting neopterin and biopterin in human urine Method.
Background technology
Neopterin and biopterin are internal GTP (GTP) metabolites, and GTP (GTP) is auxiliary Important component in enzyme tetrahydrobiopterin (tetrahy drobiopterin, BH4) building-up process, two kinds of pterins are main By urine drains, professional can effectively distinguish the parting of hyperphenylalaninemia by its content and the ratio of the two. Therefore, the antidiastole for carrying out early stage BH4 deficiency disease to HPA infants is extremely important.Atypical hyperphenylalaninemia is with passing System hyperphenylalaninemia has incomplete same therapeutic scheme, and a kind of pre-treatment of suitable clinical medical inspection is set up in exploitation Method, accurate, quickly, high-throughout chromatographic process is conducive to quickly obtaining accurate data in large quantity, contributes to professional people Member carries out corresponding assay, significant.
Containing water-soluble highly polar impurity such as a large amount of salt in urine, neopterin and biopterin easily hydrolyze again, preserve Stability is poor, is not suitable for carrying out great amount of samples detection under the HILIC patterns of high organic Phase Proportion, 25cm is used more conventional method The enhancing of C18 chromatographic columns retain and separating effect, analysis time is longer, do not meet clinical medical inspection it is quick, it is high-throughout will Ask.Meanwhile, traditional HILIC patterns, the testing cost of the method such as LC-MS is higher, is unfavorable for promoting the use of.
The content of the invention
It is an object of the invention to provide neopterin and biological butterfly in a kind of accurate, quick, high flux detection human urine The method of purine.
The technical solution used in the present invention is:
The method of neopterin and biopterin, comprises the following steps in a kind of detection human urine:
1) pre-treatment:Liquid phase detection pre-treatment is carried out to urine;
2) liquid phase is eluted:Urine sample after pre-treatment is analyzed with liquid chromatogram, the analysis condition is:
Stationary phase:Chromatographic column is reverse bonding silicagel column;
Mobile phase:A phases are methanol;B phases be 15~25mmol/L ammonium acetate buffer, and with acetic acid adjust pH 5.5~ 7.0;Gradient elution mode;
3) detect:Detected with fluorescence detector.
As the further improvement of the above method, the chromatographic column is Poroshell 120EC-C18;
As the further improvement of the above method, gradient elution mode is:
The column temperature of chromatographic column is 28~32 DEG C;
The flow velocity of mobile phase is 0.3~0.5mL/min.
As the further improvement of the above method, sample size when liquid phase is eluted is 0.5~2 μ L.
As the further improvement of the above method, testing conditions are:A length of 358~the 362nm of excitation light wave, wavelength of transmitted light For 448~452nm.
As the further improvement of the above method, before pre-treatment step, in addition to pre-treatment step, the pretreatment step Suddenly it is:5~7M hydrochloric acid is added after urine collecting immediately, freezing is kept in dark place.
As the further improvement of the above method, pre-treatment step comprises the following steps:
1) sample:Place and thaw to room temperature, mix, take sample to add centrifuge tube;
2) aoxidize:Iodine/liquor kalii iodide is added, lucifuge reaction is placed in a centrifuge after concussion;
3) neutralize:Centrifugation, ascorbic acid, sodium hydroxide, are centrifuged after the concussion that is vortexed successively;
4) filter:Supernatant is taken to cross 0.22 μm of aqueous phase filter membrane sample introduction analysis.
As the further improvement of the above method, the concentration of iodine/liquor kalii iodide is 1~5wt%, and addition is 5~15 μ L/100 μ L samples.
As the further improvement of the above method, the concentration of ascorbic acid is 1~5mg/mL, and addition is 1~5 μ L/100 μ L samples;The concentration of the sodium hydroxide is 5-10mol/L, and addition is 1~5 μ L/100 μ L samples.
It is intermittent that chromatographic column is carried out to rush post when carrying out liquid phase elution as the further improvement of the above method.
As the further improvement of the above method, the temperature of sample injection disc is 2~6 DEG C.
The beneficial effects of the invention are as follows:
The inventive method cost is low, and pre-treatment is simple, and batch processing detection can be achieved, and optimization chromatographic process shortens analysis Time, sample flux is greatly improved, be particularly suitable for use in demand of the clinical and routine testing to chromatographic process.
Brief description of the drawings
Fig. 1 is the linear regression curves of neopterin;
Fig. 2 is the linear regression curves of biopterin.
Embodiment
The method of neopterin and biopterin, comprises the following steps in a kind of detection human urine:
1) pre-treatment:Liquid phase detection pre-treatment is carried out to urine;
2) liquid phase is eluted:Urine sample after pre-treatment is analyzed with liquid chromatogram, the analysis condition is:
Stationary phase:Chromatographic column is reverse bonding silicagel column;
Mobile phase:A phases are methanol;B phases be 15~25mmol/L ammonium acetate buffer, and with acetic acid adjust pH 5.5~ 7.0;Gradient elution mode;
3) detect:Detected with fluorescence detector.
As the further improvement of the above method, the chromatographic column is Poroshell 120EC-C18;
As the further improvement of the above method, gradient elution mode is:
The column temperature of chromatographic column is 28~32 DEG C;
The flow velocity of mobile phase is 0.3~0.5mL/min.
It can be eluted under the conditions of this quickly, high-energy, improve elution effect.
As the further improvement of the above method, sample size when liquid phase is eluted is 0.5~2 μ L.
As the further improvement of the above method, testing conditions are:A length of 358~the 362nm of excitation light wave, wavelength of transmitted light For 448~452nm.
As the further improvement of the above method, before pre-treatment step, in addition to pre-treatment step, the pretreatment step Suddenly it is:5~7M hydrochloric acid is added after urine collecting immediately, freezing is kept in dark place.
As the further improvement of the above method, pre-treatment step comprises the following steps:
1) sample:Place and thaw to room temperature, mix, take sample to add centrifuge tube;
2) aoxidize:Iodine/liquor kalii iodide is added, lucifuge reaction is placed in a centrifuge after concussion;
3) neutralize:Centrifugation, ascorbic acid, sodium hydroxide, are centrifuged after the concussion that is vortexed successively;
4) filter:Supernatant is taken to cross 0.22 μm of aqueous phase filter membrane sample introduction analysis.
As the further improvement of the above method, the concentration of iodine/liquor kalii iodide is 1~5wt%, and addition is 5~15 μ L/100 μ L samples.
As the further improvement of the above method, the concentration of ascorbic acid is 1~5mg/mL, and addition is 1~5 μ L/100 μ L samples;The concentration of the sodium hydroxide is 5-10mol/L, and addition is 1~5 μ L/100 μ L samples.
It is intermittent that chromatographic column is carried out to rush post when carrying out liquid phase elution as the further improvement of the above method.
As the further improvement of the above method, the temperature of sample injection disc is 2~6 DEG C.At this temperature, it is more beneficial for keeping The stability of sample, while being had no adverse effect substantially to liquid phase elution.
With reference to embodiment, technical scheme is further detailed.
Embodiment 1
1st, the collection of people source urine and Sample storage
Three, freshly voided urine sample is gathered, every sample adds 6M HCl to adjust after pH to 1 or so respectively, and lucifuge is put respectively Deposit, every 0, each determine once within 1,2,5,8,15,22 days under the conditions of -20 DEG C and -70 DEG C.
2nd, the pre-treatment of urine sample
1) sample:Place and thaw to room temperature, mixing take the μ L of acidified sample 420 to 1.5mL centrifuge tubes;
2) aoxidize:The μ L of 1% iodine/liquor kalii iodide 30 are added, 3min is shaken, lucifuge in 4 DEG C of centrifuges is placed in and reacts 30min;
3) neutralize:Short centrifugation 3 seconds, sequentially adds 5 μ L 2mg/mL ascorbic acid, and 15 μ L 6M sodium hydroxides are vortexed and shaken 3min, 4 DEG C, 12000rpm centrifugations 5min;
4) filter:Supernatant is pipetted using 2.0mL disposable syringes and crosses 0.22 μm of aqueous phase filter membrane sample introduction analysis.
3rd, pattern detection
Liquid-phase condition
Chromatographic column:Poroshell 120EC-C18 (2.1 × 100mm, 2.7 μm)
Mobile phase A=methanol
Mobile phase B=20mmol/L ammonium acetate buffers, acetic acid adjusts pH6.0
Detection wavelength:Ex360nm, Em450nm, peak width 74.07HZ
Column temperature:30℃
Sample size:1μL
Sample injection disc temperature:5℃
Flow velocity:0.4mL/min
Retention time:NP 1.2min, BP 3.3min
Retention time window:5%
Width:0.1
Threshold value:50.
Method validation
Sensitivity for analysis and range of linearity result
Neopterin linear regression curves are as shown in Figure 1;
Biopterin linear regression curves are as shown in Figure 2.
The method degree of accuracy
The rate of recovery of neopterin between 88.1%~114.5%, the rate of recovery of biopterin 93.3%~ 107.8%, meet 85%-115% requirement.
Precision
Withinrun precision and betweenrun precision are respectively less than 20%, meet the requirements.
Neopterin Precision Experiment result collects
Biopterin Precision Experiment result collects
Sample shelf stability
- 20 DEG C of storages of lucifuge, neopterin stability data
- 20 DEG C of storages of lucifuge, biopterin stability data
- 70 DEG C of storages of lucifuge, neopterin stability data
- 70 DEG C of storages of lucifuge, biopterin stability data
It was found from the data in table, urine specimen can under the conditions of -20 DEG C of lucifuge stable storage 5 days, -70 DEG C of conditions of lucifuge Under can stablize storage 15 days.

Claims (10)

1. a kind of method for detecting neopterin and biopterin in human urine, comprises the following steps:
1) pre-treatment:Liquid phase detection pre-treatment is carried out to urine;
2) liquid phase is eluted:Urine sample after pre-treatment is analyzed with liquid chromatogram, the analysis condition is:
Stationary phase:Chromatographic column is reverse bonding silicagel column;
Mobile phase:A phases are methanol;B phases are 15~25mmol/L ammonium acetate buffer, and adjust pH 5.5~7.0 with acetic acid;
Gradient elution mode;
3) detect:Detected with fluorescence detector.
2. according to the method described in claim 1, it is characterised in that:In the liquid phase elution step:
The chromatographic column is the EC-C18 of Poroshell 120;
The gradient elution mode is:
The column temperature of chromatographic column is 28~32 DEG C;
The flow velocity of mobile phase is 0.3~0.5mL/min.
3. method according to claim 1 or 2, it is characterised in that:Sample size when liquid phase is eluted is 0.5~2 μ L.
4. method according to claim 1 or 2, it is characterised in that:Testing conditions are:Excitation light wave a length of 358~ 362nm, wavelength of transmitted light is 448~452nm.
5. according to the method described in claim 1, it is characterised in that:Before the pre-treatment step, in addition to pre-treatment step, The pre-treatment step is:5~7M hydrochloric acid is added after urine collecting immediately, freezing is kept in dark place.
6. method according to claim 1 or 5, it is characterised in that:The pre-treatment step comprises the following steps:
1) sample:Place and thaw to room temperature, mix, take sample to add centrifuge tube;
2) aoxidize:Iodine/liquor kalii iodide is added, lucifuge reaction is placed in a centrifuge after concussion;
3) neutralize:Centrifugation, sequentially adds ascorbic acid, sodium hydroxide, is centrifuged after the concussion that is vortexed;
4) filter:Supernatant is taken to cross 0.22 μm of aqueous phase filter membrane sample introduction analysis.
7. method according to claim 6, it is characterised in that:The concentration of the iodine/liquor kalii iodide is 1~5wt%, plus Enter amount for 5~15 μ L/100 μ L samples.
8. method according to claim 6, it is characterised in that:The concentration of the ascorbic acid is 1~5mg/mL, addition For 1~5 μ L/100 μ L samples;The concentration of the sodium hydroxide is 5-10mol/L, and addition is 1~5 μ L/100 μ L samples.
9. according to the method described in claim 1, it is characterised in that:It is intermittent that chromatographic column is carried out when carrying out liquid phase elution Rush post.
10. according to the method described in claim 1, it is characterised in that:The temperature of sample injection disc is 2~6 DEG C.
CN201710373546.5A 2017-05-24 2017-05-24 method for detecting neopterin and biopterin in human urine Active CN107290444B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710373546.5A CN107290444B (en) 2017-05-24 2017-05-24 method for detecting neopterin and biopterin in human urine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710373546.5A CN107290444B (en) 2017-05-24 2017-05-24 method for detecting neopterin and biopterin in human urine

Publications (2)

Publication Number Publication Date
CN107290444A true CN107290444A (en) 2017-10-24
CN107290444B CN107290444B (en) 2019-12-06

Family

ID=60095065

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710373546.5A Active CN107290444B (en) 2017-05-24 2017-05-24 method for detecting neopterin and biopterin in human urine

Country Status (1)

Country Link
CN (1) CN107290444B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109946412A (en) * 2017-12-21 2019-06-28 上海产业技术研究院 A kind of body fluid pterin spectrum detection kit and its use
CN111505179A (en) * 2020-04-07 2020-08-07 厦门大学 Method for detecting biopterin in marine water body
CN113125611A (en) * 2021-04-22 2021-07-16 北京斯利安药业有限公司 Method for detecting content of impurity 6-formyl pterin folic acid
CN114814063A (en) * 2022-04-08 2022-07-29 宁波熙宁检测技术有限公司 Method for detecting tetrahydrobiopterin in human body

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500511A1 (en) * 2003-07-14 2006-01-15 Hausen Arnulf Dr METHOD FOR DETERMINING THE NUTRITIONAL AND / OR HEALTH STATUS OF ANIMALS
JP2007163434A (en) * 2005-12-16 2007-06-28 Hamamatsu Photonics Kk Data processing method
AT500529B1 (en) * 2003-07-14 2008-08-15 Hausen Arnulf Dr Elimination of bovine spongiform enzephalopathy from excrement of cattle or the excrement produced substances and excrement liquid, comprises detecting the substance similar to neopterin by high speed liquid chromatography
US20110147217A1 (en) * 2009-12-17 2011-06-23 The Curators Of The University Of Missouri Method and apparatus for cancer screening

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500511A1 (en) * 2003-07-14 2006-01-15 Hausen Arnulf Dr METHOD FOR DETERMINING THE NUTRITIONAL AND / OR HEALTH STATUS OF ANIMALS
AT500529B1 (en) * 2003-07-14 2008-08-15 Hausen Arnulf Dr Elimination of bovine spongiform enzephalopathy from excrement of cattle or the excrement produced substances and excrement liquid, comprises detecting the substance similar to neopterin by high speed liquid chromatography
JP2007163434A (en) * 2005-12-16 2007-06-28 Hamamatsu Photonics Kk Data processing method
US20110147217A1 (en) * 2009-12-17 2011-06-23 The Curators Of The University Of Missouri Method and apparatus for cancer screening

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
崔盼盼等: "高效液相色谱-荧光检测法同时测定人体尿液中的多种蝶呤类化合物", 《分析科学学报》 *
张惠静等: "高效液相色谱法测定血清新喋吟", 《分析仪器》 *
白波等: "高效液相色谱-荧光检测法在小儿尿蝶呤分析中的新应用", 《药物分析杂志》 *
谭婷等: "高效液相色谱法测定生物样品中多种蝶呤类化合物", 《分析试验室》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109946412A (en) * 2017-12-21 2019-06-28 上海产业技术研究院 A kind of body fluid pterin spectrum detection kit and its use
CN111505179A (en) * 2020-04-07 2020-08-07 厦门大学 Method for detecting biopterin in marine water body
CN111505179B (en) * 2020-04-07 2021-07-13 厦门大学 Method for detecting biopterin in marine water body
CN113125611A (en) * 2021-04-22 2021-07-16 北京斯利安药业有限公司 Method for detecting content of impurity 6-formyl pterin folic acid
CN113125611B (en) * 2021-04-22 2023-04-18 北京斯利安药业有限公司 Method for detecting content of impurity 6-formyl pterin folic acid
CN114814063A (en) * 2022-04-08 2022-07-29 宁波熙宁检测技术有限公司 Method for detecting tetrahydrobiopterin in human body

Also Published As

Publication number Publication date
CN107290444B (en) 2019-12-06

Similar Documents

Publication Publication Date Title
CN107290444A (en) The method for detecting neopterin and biopterin in human urine
CN102735768B (en) Process for jointly detecting estrogens and their associations in livestock and poultry excrements
CN105092765A (en) Detection method for effective components in ganoderma lucidum spore powder raw material
CN109142572A (en) A variety of drugs are synchronous in a kind of environment multimedium extracts and determination method
CN103713077A (en) Method for determining content of gamma-aminobutyric acid in red yeast through high-efficient liquid chromatography
CN111781290A (en) Kit and detection method for accurately determining blood concentration of multiple antiepileptic drugs in human serum
CN102081078A (en) Method for measuring residual quantities of four fluoroquinolone medicaments in animal food
CN101696964A (en) Solid phase extraction and HPLC-fluorescence detection method for fluoroquinolones antibiotics
CN104215705B (en) A kind of method detecting Organochlorine Pesticides Residues In Agricultural Products
CN103630633A (en) Method for measuring contents of six amino acids in ixeris sonchifolia injection by using pre-column derivatization method
CN103852531A (en) Method for detecting malto-oligosaccharide in beer through HPLC-ELSD (High-Performance Liquid Chromatography-Evaporative Light Scattering Detector)
CN106338559B (en) A kind of gas-chromatography detection method of chlorine disinfection by-product dichloro acetamide
CN107202840A (en) A kind of method for detecting 4 kinds of barbiturates downerns of fresh milk
CN104359993B (en) A kind of detection method of ambrisentan related substance
CN108072717B (en) Method for detecting arginine solution
CN111579684B (en) Method for measuring content of total capsaicin in capsule wall material of capsule
CN102590372A (en) Method for detecting types and contents of phenolic acid in flue-cured tobacco root system secretion
CN104777139A (en) Method for detecting total mercury, inorganic mercury and organic mercury in tobacco simultaneously and application
CN104833757B (en) Method of simultaneously determining multiple chemical drugs illegally added in soft capsule health food
CN111505178A (en) Separation and determination method for migration rate of nicotine optical isomer in cigarettes
CN111398494A (en) Nicotine optical isomer separation and determination method based on reversed-phase two-dimensional liquid chromatography
CN104833760A (en) Method for using high-performance liquid chromatography to measure greenhouse tomato soil low-molecular-weight organic acids
Chen et al. Chemiluminescence flow sensor with immobilized reagent for the determination of pyrogallol based on potassium hexacyanoferrate (III) oxidation
CN103755823A (en) Purification and detection method for keratan sulfate in chondroitin sulfate
CN103926368A (en) Method for extracting biotin from corn steep liquor and thin layer chromatography (TLC) scanning detection method of biotin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant